phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

As the debate in Washington around drug pricing proposals continues to intensify, a new Ipsos/PhRMA poll shows Medicare “negotiation” is not nearly as popular as some might suggest. Survey findings show that public opinion dips by nearly 50 points, overall, when Americans are presented with information both in support of and against Medicare “negotiations.”

This survey also sheds light on what should be an integral facet of the ongoing policy debate: Americans’ true health care priorities. These include protecting access to medicines and innovation, lowering health care out-of-pocket costs and reaching pragmatic policy solutions. Key findings include:

Support for Medicare “negotiation” plummets once people learn more about the policy proposal. When told that the measure could limit people’s access to newer prescription medicines, initial support drops from 63% to 14%.

21_10_190 PhRMA IPSOS Onepager_FB[1]

Notably, there is a shift in key demographics. After learning that the proposal could limit access, support for “negotiation” drops among Democrats (by 61 points), seniors (by 58 points), Hispanic Americans (by 51 points), and Black Americans (by 47 points). Similarly, only 15% of people support negotiation when told that taxing medicines up to 95% for non-compliance could take money out of the search for new medicines and cures.

Americans want policymakers to prioritize addressing insurance costs and out-of-pocket costs over prescription drug prices. Americans’ top health care concerns include insurance costs (44%); the pandemic (37%); bureaucracy, inefficiency and waste in the system (30%); and out-of-pocket expenses (28%). Only 26% of Americans cited prescription drug costs as a major issue. And when given the choice, 77% say Congress should focus more on reducing the overall costs of health care coverage, such as premiums, deductibles and copays, versus focusing more on reducing the costs of prescription medicines (22%).

Americans broadly support policy proposals that enable government oversight and address their more pressing concerns around health insurance coverage. Seventy-two percent of Americans believe the federal government should provide oversight and incentives to health care providers, prescription drug companies and health insurers to encourage more competition to lower prices in the health care system versus setting prices for health care services and prescription medicines and determining what services and medicines are covered by private health plans (27%).

Americans are abundantly clear on their priorities: 86% of Americans feel like politicians have lost touch with what the public needs from their health care. These survey findings reinforce the need for policymakers to address the most pressing concerns and priorities of patients through pragmatic solutions, not government price setting.

Learn more about PhRMA’s patient-centered, commonsense solutions that would address patient’s true concerns and voices. 

Download a fact sheet about the poll here.

For more details on the Ipsos/PhRMA poll click here.

Cynthia Hicks

Cynthia Hicks is Senior Director of Public Affairs at PhRMA focusing on polling and opinion research that supports advocacy communications and strategy. Prior to joining PhRMA, Cynthia worked as a consultant, marketer, and head of polling for a civic technology company where her work supported issue advocacy organizations and policy makers on both sides of the aisle. Cynthia is a proud Los Angeles native and outside of the office she enjoys an early morning HIIT workout and spending time with friends and family.

Cynthia Hicks

What AARP isn’t telling seniors about MFN

August 24, 2026

CMS proposal could discourage patient-centered innovation

August 18, 2026

Nearly 1 in 4 patients initially denied access to IRA medicines

August 6, 2026

Medicare Part D at 20: Building on a strong foundation

July 23, 2026

New poll shows Americans reject Medicare negotiation once they learn more about the policy

Drug Cost

Medicare

Policy Solutions

Polling

New poll shows Americans reject Medicare negotiation once they learn more about the policy

October 15, 2021

New poll shows Americans reject Medicare negotiation once they learn more about the policy

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list